Does BETAXOLOL Cause Low density lipoprotein increased? 10 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Low density lipoprotein increased have been filed in association with BETAXOLOL (Betoptic S). This represents 1.6% of all adverse event reports for BETAXOLOL.
10
Reports of Low density lipoprotein increased with BETAXOLOL
1.6%
of all BETAXOLOL reports
0
Deaths
10
Hospitalizations
How Dangerous Is Low density lipoprotein increased From BETAXOLOL?
Of the 10 reports, 10 (100.0%) required hospitalization.
Is Low density lipoprotein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BETAXOLOL. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does BETAXOLOL Cause?
Treatment failure (111)
Hypersensitivity (85)
Fall (66)
Drug ineffective (51)
Asthma (45)
Cardiac disorder (45)
Dizziness (42)
Bradycardia (38)
Dyspnoea (38)
Glaucoma (38)
What Other Drugs Cause Low density lipoprotein increased?
EVOLOCUMAB (1,024)
INCLISIRAN (423)
ALIROCUMAB (336)
ROSUVASTATIN (241)
ATORVASTATIN (217)
EZETIMIBE (217)
LOMITAPIDE (164)
TOFACITINIB (135)
FINGOLIMOD (132)
SOMATROPIN (93)
Which BETAXOLOL Alternatives Have Lower Low density lipoprotein increased Risk?
BETAXOLOL vs BETHANECHOL
BETAXOLOL vs BEVACIZUMAB
BETAXOLOL vs BEVACIZUMAB-AWWB
BETAXOLOL vs BEVACIZUMAB-BVZR
BETAXOLOL vs BEVACIZUMAB-MALY